Showing results (321-330 of 1,998) with videos related to

Sort By:
Pageof 200
Endocrine, Metabolic & Immune Disorders Drug Targets|March 24, 2023
In vitro Pretreatment with Zinc Alleviates the Adverse Effects of Tetrahydrocannabinol on Cultured Mouse Sertoli Cells: Role of Anti-apoptotic and Antioxidant ActivitiesKimia Ahmadi, Fatemeh Asgharzadeh, Shadi Mohammadpour-Asl, et al.
Endocrine, Metabolic & Immune Disorders Drug Targets|February 27, 2023
Evaluation of Endocrine Related Adverse Effects of Non-Endocrine Targeted Pharmaceuticals in Cellular SystemsBita Entezari, Deniz Bozdag, Hande Gurer-Orhan
Endocrine, Metabolic & Immune Disorders Drug Targets|May 21, 2020
The Cannabis Spread throughout the Continents and its Therapeutic Use in HistoryIoannis A Charitos, Roberto Gagliano-Candela, Luigi Santacroce, et al.
Endocrine, Metabolic & Immune Disorders Drug Targets|May 21, 2020
Insights into Transdermal Drug Delivery: Approaches for Redressal of a Burgeoning Issue of OsteoporosisFoziyah Zakir, Kanchan Kohli, Farhan J Ahmad, et al.
Endocrine, Metabolic & Immune Disorders Drug Targets|May 21, 2020
Oxytocin Signaling Pathway: From Cell Biology to Clinical ImplicationsMichele Iovino, Tullio Messana, Anna Tortora, et al.
Endocrine, Metabolic & Immune Disorders Drug Targets|May 26, 2020
A Pre-Post Study of Vitamin D Supplement Effects on Urinary Megalin: The Emerging Predictive Role of Megalin in Diabetic Nephropathy ProgressionViolet Kasabri, Amal Akour, Nailya Bulatova, et al.
Endocrine, Metabolic & Immune Disorders Drug Targets|August 9, 2021
Subclinical Hypothyroidism in Patients with Diabetic Retinopathy: Role of Vascular Endothelial Growth FactorAmr A El-Sehrawy, Enas M Elkhamisy, Amani E Badawi, et al.
Endocrine, Metabolic & Immune Disorders Drug Targets|September 9, 2021
In vitro Cholesterol Assimilation by Bifidobacterium animalis subsp. lactis (BPL1) Probiotic Bacteria Under Intestinal ConditionsMaría Coronada Fernández-Calderón, María Dolores Hinchado Sánchez-Moro, Eduardo Ortega Rincón
Endocrine, Metabolic & Immune Disorders Drug Targets|September 14, 2021
WITHDRAWN: The Application of Sheng-Mai Injection in Diabetes Mellitus and Related Complications: A Systematic Review and MetaanalysisMaoyi Yang, Zhipeng Hu, Rensong Yue
Pageof 200